Stockscreener 앱 받기
0.50
0.00%
0.00
시간 외 거래:
.49
-0.01
-2.00%
Medicus Pharma Ltd 주식(MDCX)의 최신 뉴스
Analyst Calls: Is Medicus Pharma Ltd exposed to currency risks2026 Price Swings & Technical Entry and Exit Tips - baoquankhu1.vn
Medicus Pharma to host fireside chat on SkinJect trial results By Investing.com - Investing.com South Africa
MDCXW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Will Medicus Pharma Ltd outperform the market in YEARDividend Hike & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Medicus Pharma prices $7 million share offering - MSN
Medicus Pharma on Bloomberg World - Journal & Courier
Medicus Pharma Showcases Strong Phase 2 SkinJect Data Ahead of Fireside Chat - TipRanks
Medicus Pharma to host fireside chat on SkinJect trial results - Investing.com
Medicus Pharma To Discuss Positive Skinject(R) Phase 2 Topline Results In Fireside Chat Hosted By Brookline Capital Markets Biotechnology Equity Research Analyst - standard-journal.com
Microneedle therapy cleared 73% of basal cell lesions, may help patients avoid surgery - Stock Titan
Aug Sectors: What is the dividend yield of Medicus Pharma Ltd Equity Warrant2026 Sector Moves & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Medicus Pharma schedules webcast on basal cell carcinoma study By Investing.com - Investing.com India
Aug Opening: Is Medicus Pharma Ltd Equity Warrant a speculative investment2026 Volume & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Medicus reports phase 2 results for SkinJect basal cell carcinoma study - MSN
Investment Recap: Can Medicus Pharma Ltd sustain its profitabilityTrade Exit Report & Technical Entry and Exit Tips - baoquankhu1.vn
Medicus Pharma to highlight positive Phase 2 SkinJect data during webcast with lead investigator - Proactive financial news
Medicus Pharma Highlights Strong Phase 2 SkinJect Data Ahead of Business Update Call - TipRanks
Medicus Pharma schedules webcast on basal cell carcinoma study - Investing.com
Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webcast on March 26 - ChartMill
Medicus Pharma CEO discusses promising Phase 2 SkinJect resultsICYMI - Proactive financial news
Medicus Pharma Marks Nasdaq Anniversary with Opening Bell Ceremony - The Globe and Mail
Medicus Pharma reports positive phase 2 results for SkinJect skin cancer therapy - MSN
Risk Report: Will Medicus Pharma Ltd outperform the market in YEAR2026 Update & High Accuracy Investment Signals - baoquankhu1.vn
Medicus Pharma receives FDA clearance to begin Phase 2b Teverelix study - MSN
Medicus Pharma to Spotlight AI-Driven Drug Development at Longwood Miami CEO Forum - The Globe and Mail
Medicus Pharma reports phase 2 results for basal cell carcinoma therapy - MSN
Medicus Pharma Reports Phase 2 Results for Basal Cell Carcinoma Therapy - MyChesCo
Medicus Pharma to spotlight AI-driven drug development at Longwood Miami CEO Forum - Proactive financial news
Medicus Pharma to Showcase AI-Enabled Drug Development at Longwood Miami CEO Forum - National Today
Medicus Pharma Ltd. To Participate In The Longwood Miami CEO Forum - News-Press NOW
Faster, cheaper trials: Medicus Pharma brings AI strategy to Miami forum - Stock Titan
Medicus Pharma to Present Drug Development Programs at Roth Conference - MyChesCo
MDCX Maintains Buy Rating with Stable Price Target | MDCX Stock News - GuruFocus
Small cap wrap: Medicus Pharma, C3 Metals, Protalix BioTherapeutics… - Proactive financial news
Medicus Pharma provides additional Phase 2 data for SkinJect Cancer therapy - Proactive financial news
Medicus Pharma Highlights Strong Phase 2 SkinJect Results in Basal Cell Carcinoma - TipRanks
Medicus says Phase 2 data supports further development of SkinJect therapy for skin cancer - Proactive financial news
Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Dataset - The Manila Times
Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect Dataset - Bitget
Aug Ideas: Can Medicus Pharma Ltd Equity Warrant disrupt its industryWeekly Market Outlook & Free Accurate Trade Setup Notifications - baoquankhu1.vn
0.33%
0.99%
자본화:
|
볼륨(24시간):